Advanced Medical Isotope Corp. (OTCMKTS:ADMD) stock performance has been decent as the ticker managed to post some impressive gains. Even in last trading session, the stock price of Advanced Medial surged more than 11% to close the trading session at $0.00470. The gains came at a share volume of 35.61 million compared to average share volume of 49.21 million.

The performance

Advanced Medical stock took a temporary hit when it released its quarterly report for first quarter of FY2015. As per the report, it had cash of $2,485. The current assets and current liabilities came at $31,760 and $21.25 million, respectively. The revenue in quarter was $12,054 while operating loss came at $328,813. The numbers indicate dismal performance in the quarter. When the dilution that company’s shareholders witnessed last year and in this year, is considered picture becomes much uglier.

The dilution

The balance sheet may be adequately discouraging even on its own but shareholders have a lot more to be concerned about. The long-term shareholders have had to suffer through a devastating amount of dilution. At the end of FY2013, Advanced Medical had less than 121 million outstanding shares, which has surged to over 1.7 billion in just 12 months. The problem is almost 1.2 billion of the shares issued last year came into existence due to debt conversion. In 2015 the situation has remained more or less the same with another round of shares being issued at discounted prices. In first week of May, the outstanding shares count stood at 1.97 billion.

The momentum

Since February 2015, the stock performance of Advanced Medical Isotope Corp. (OTCMKTS:ADMD) has been amazing. It has surged more than 1000% from its lows of $0.0006. The recent positive momentum can be attributed to management’s plan of improving overall capital structure that supported investors’ confidence. However, the quarterly numbers released last week are not decent enough to support further upward momentum in the stock.